Targeting glioma-initiating cells via the tyrosine metabolic pathway is a research paper published in Journal of neurosurgery (2020). On theSindex it has a DataRank of 0.564. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA183991
NCI NIH HHS
Grant: P50 CA211015
NINDS NIH HHS
Grant: R01 NS087913
NCI NIH HHS
Grant: R01 CA201402
NINDS NIH HHS
Grant: R01 NS083767
National Institutes of Health
Grant: 5R01NS083767-05
Targeting MELK-mediated EZH2 signaling in glioma stem cells
National Institutes of Health
Grant: 5R01NS087913-04
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
National Institutes of Health
Grant: 5R01CA183991-03
Novel role of compensatory proliferation in human brain tumor
National Institutes of Health
Grant: 5R01CA201402-07
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers
FWCI
2.71
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals